All Posts

Read the latest from Streit and Colleagues

 UF Neuroscientists look deeper into dystrophic microglia in late-onset Alzheimer’s disease (AD). Studies conducted were done so by neuropathological analysis of post-mortem human brains with special attention paid to microglia, as these cells are important in cellular processes that lead to AD-type neurodegeneration. After finding an in situ correlation between…

Read the latest from Tansey and colleagues

Neuroscientists from University of Florida investigate plasma proteins’ influence on peripheral and central inflammation in depression. Peripheral blood C-reactive protein (CRP) is a biomarker used clinically to measure systemic inflammation. Patients with major depressive disorder (MDD) show increased amounts of CRP. Increased peripheral blood CRP in MDD has been associated…

Upcoming NCF SfN Virtual Conference with Dr. Steven Maier

Join us for the first ever North Central Florida Society for Neuroscience (NCF SfN) Virtual Conference on February 19th, 2021. This year’s conference will offer a chance to exchange scientific discoveries, network, and present to fellow neuroscientists across the North Central Florida region. The North Central Florida region includes, but…

Read the latest from the Khoshbouei Group

University of Florida neuroscientists make breakthroughs in research regarding Parkinson’s disease (PD) in rodent model. The findings indicate both dopamine neuron loss protection and improved motor deficits due to alterations with gut microbiota and antibiotics. With PD affecting approximately 10 million worldwide with degeneration of motor and non-motor…

Read the Latest from Khoshbouei Group

New study from the University of Florida Department of Neuroscience finds anti-inflammatory agents do not yield beneficial effects in treating addiction disorders. Methamphetamine (METH), a psychostimulant subject to abuse worldwide, is widely recognized for its effects on dopamine neurotransmission and the central nervous system (CNS). In recent years, questions of…

Read the latest from the Borchelt Group

Drs. Jake Ayres and Dave Borchelt publish a new review in Acta Neuropathologica on phenotypic diversity in amyotrophic lateral sclerosis (ALS).  In many types of familial amyotrophic lateral sclerosis (fALS), mutations…

Congratulations Kalene Jasso on new NIH predoctoral fellowship

Kalene Jasso was awarded a new individual predoctoral fellowship from NIH entitled “The Role of MCHR1 Signaling in Olfactory Function”.   The goal of this project is to increase our understanding of mechanisms that modulate the sense of smell. The project will investigate the role of the melanin-concentrating hormone receptor (MCHR1) in…

Dr. Ashok Kumar Awarded new R21 from NIH

Dr. Ashok Kumar, a Research Associate Professor in the Department of Neuroscience was recently awarded a new R21 from NIA entitled Age-associate impaired executive function: Rescue by NMDA receptor upregulation.